Authors:
Punt, CJA
van Maanen, L
Bol, CJJG
Seifert, WF
Wagener, DJT
Citation: Cja. Punt et al., Phase I and pharmacokinetic study of the ovally administered farnesyl transferase inhibitor R115777 in patients with advanced solid tumors, ANTI-CANC D, 12(3), 2001, pp. 193-197
Authors:
Wagenaar, HC
Pecorelli, S
Vergote, I
Curran, D
Wagener, DJT
Kobierska, A
Bolis, G
ten Bokkel-Huinink, W
Lacave, AJ
Madronal, C
Forni, M
de Oliveira, CF
Mangioni, C
Nooij, MA
Goupil, A
Kerbrat, P
Marth, C
Tumolo, S
Herben, MG
Zanaboni, F
Vermorken, JB
Citation: Hc. Wagenaar et al., Phase II study of a combination of cyclophosphamide, adriamycin and cisplatin in advanced Fallopian tube carcinoma - An EORTC Gynecological Cancer Group Study, EUR J GYN O, 22(3), 2001, pp. 187-193
Citation: Yjl. Kamm et al., Effect of carbogen breathing on the pharmacodynamics of 5-fluorouracil in a murine colon carcinoma, EUR J CANC, 36(9), 2000, pp. 1180-1186
Citation: Dl. Schipper et al., Glutathione S-transferases and iododeoxyuridine labelling index during chemotherapy of gastric cancer, ANTICANC R, 20(3A), 2000, pp. 1705-1710
Citation: Dl. Schipper et al., Correlation between iododeoxyuridine and MIB-1 labelling index in gastric carcinoma and adjacent normal gastric tissue, ANTICANC R, 20(2A), 2000, pp. 707-714
Authors:
Awada, A
Punt, CJA
Piccart, MJ
Van Tellingen, O
Van Manen, L
Kerger, J
Groot, Y
Wanders, J
Verweij, J
Wagener, DJT
Citation: A. Awada et al., Phase I study of Carzelesin (U-80,244) given (4-weekly) by intravenous bolus schedule, BR J CANC, 79(9-10), 1999, pp. 1454-1461